Hound Labs
Oakland
About Hound Labs
Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective result to support workplace policies that prohibit use immediately before or during the workday, but do not penalize employees for cannabis use away from work. Founded in 2014, Hound Labs is headquartered in Fremont, California. Benchmark, EEC, Icon Ventures, Intrinsic Capital Partners, NFP Ventures, Tuatara Capital, and individual investors have funded the Company. Learn more at HoundLabs.com.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $130.1M
- Last round: Debt Financing (Oct 2021)
- Website: houndlabs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hound-labs-89529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.